Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa proof-of-concept trial of PARENTIDE for neuropathic pain due to peripheral nerve injury
2016-002846-21Phase 2Terminated
- Sponsor
- BCN Peptides
- Start
- Jan 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Neuralgia comparing PARENTIDE with Placebo (2 arms). Primary endpoint: Intensity of pain in the evening. Started Jan 2017; status: terminated.
02
Drugs
parentide
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2016-002846-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002846-21.